+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Parenteral Nutrition Market By Nutrient Type (Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, and Vitamins & Minerals), By Country, Growth Potential, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027

  • PDF Icon

    Report

  • 64 Pages
  • August 2021
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5448263

The Latin America, Middle East and Africa Parenteral Nutrition Market is expected to witness market growth of 9% CAGR during the forecast period (2021-2027).

Malnutrition is one of the major driving factors for the development of the parenteral nutrition market. As per the UNICEF, if an infant suffers malnutrition during his first 1,000 days of life could result in impaired cognitive ability and unstable growth. The diet of an infant should have an appropriate balance of vitamins, starch, amino acids, minerals, and lipids. These necessary nutrients can be administered through parenteral nutrition, which is likely to accelerate the growth of the parenteral nutrition market during the forecasting period.

The surge in the occurrences of chronic diseases like cancer positively impacts the adoption of parenteral nutrition across the globe. In addition, parenteral nutrition is extremely beneficial in the administration of essential nutrition that is highly helpful for strength, hydration, and energy level among the patients during their treatment.

The region is witnessing a constant surge in the number of premature infants who are highly vulnerable to stunt growth and catching infections. Therefore, early parenteral nutrition is crucial for preterm infants and must transfer appropriate amino acids & energy. The market players are capitalizing on this opportunity by actively entering the regional market and putting investments in different strategies in order to gain a competitive edge.

High accessibility with ultra-modern supply chain solutions is expected to fuel the growth of the regional parenteral nutrition market in the upcoming years. Moreover, the adoption of parenteral nutrition has been increased in end-user verticals such as diagnostic centers, hospitals, and clinics in order to avoid infections and to maintain hygiene levels. Hence, these factors is expected to open new avenues for growth for the regional parenteral nutrition market.

The Single Dose Amino Acid Solution market dominated the South Africa Parenteral Nutrition Market by Nutrient Type in 2020, thereby, achieving a market value of $54.6 million by 2027. The Parenteral Lipid Emulsion market is estimated to grow at a CAGR of 8.8% during (2021 - 2027). Additionally, The Carbohydrates market is expected to witness highest CAGR of 10.3% during (2021 - 2027).

Based on Nutrient Type, the market is segmented into Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, and Vitamins & Minerals. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.



The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Vifor Pharma Management Ltd., Baxter International, Inc., Allergan PLC (AbbVie), B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Grifols S.A., Pfizer, Inc., ICU Medical, Inc., Anhui Medipharm Co., Ltd. and Aculife Healthcare Private Limited.



Scope of the Study

Market Segments Covered in the Report:


By Nutrient Type

  • Single Dose Amino Acid Solution
  • Parenteral Lipid Emulsion
  • Carbohydrates
  • Trace Elements,
  • Vitamins & Minerals

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:


  • Vifor Pharma Management Ltd.
  • Baxter International, Inc.
  • Allergan PLC (AbbVie)
  • B.Braun Melsungen AG
  • Fresenius SE & Co. KGaA
  • Grifols S.A.
  • Pfizer, Inc.
  • ICU Medical, Inc.
  • Anhui Medipharm Co., Ltd.
  • Aculife Healthcare Private Limited

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Parenteral Nutrition Market, by Nutrient Type
1.4.2 LAMEA Parenteral Nutrition Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 COVID-19 Impact
2.1.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Parenteral Nutrition Market by Nutrient Type
3.1 LAMEA Single Dose Amino Acid Solution Market by Country
3.2 LAMEA Parenteral Lipid Emulsion Market by Country
3.3 LAMEA Carbohydrates Market by Country
3.4 LAMEA Trace Elements Market by Country
3.5 LAMEA Other Nutrient Type Market by Country
Chapter 4. LAMEA Parenteral Nutrition Market by Country
4.1 Brazil Parenteral Nutrition Market
4.1.1 Brazil Parenteral Nutrition Market by Nutrient Type
4.2 Argentina Parenteral Nutrition Market
4.2.1 Argentina Parenteral Nutrition Market by Nutrient Type
4.3 UAE Parenteral Nutrition Market
4.3.1 UAE Parenteral Nutrition Market by Nutrient Type
4.4 Saudi Arabia Parenteral Nutrition Market
4.4.1 Saudi Arabia Parenteral Nutrition Market by Nutrient Type
4.5 South Africa Parenteral Nutrition Market
4.5.1 South Africa Parenteral Nutrition Market by Nutrient Type
4.6 Nigeria Parenteral Nutrition Market
4.6.1 Nigeria Parenteral Nutrition Market by Nutrient Type
4.7 Rest of LAMEA Parenteral Nutrition Market
4.7.1 Rest of LAMEA Parenteral Nutrition Market by Nutrient Type
Chapter 5. Company Profiles
5.1 Vifor Pharma Management Ltd.
5.1.1 Company Overview
5.1.2 Financial Analysis
5.1.3 Research & Development Expenses
5.2 Baxter International, Inc.
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Regional Analysis
5.2.4 Research & Development Expense
5.2.1 Recent strategies and developments:
5.2.1.1 Partnerships, Collaborations, and Agreements:
5.2.1.2 Product Launches and Product Expansions:
5.2.1.3 Approvals and Trails:
5.3 Allergan PLC (AbbVie)
5.3.1 Company Overview
5.3.2 Financial Analysis
5.3.3 Regional Analysis
5.3.4 Research & Development Expense
5.4 B. Braun Melsungen AG
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Segmental and Regional Analysis
5.4.4 Research & Development Expenses
5.5 Fresenius SE & Co. KGaA
5.5.1 Company Overview
5.5.2 Financial Analysis
5.5.3 Segmental and Regional Analysis
5.5.4 Research & Development Expenses
5.6 Grifols S.A.
5.6.1 Company Overview
5.6.2 Financial Analysis
5.6.3 Segmental and Regional Analysis
5.6.4 Research & Development Expense
5.7 Pfizer, Inc.
5.7.1 Company Overview
5.7.2 Financial Analysis
5.7.3 Regional Analysis
5.7.4 Research & Development Expenses
5.8 ICU Medical, Inc.
5.8.1 Company Overview
5.8.2 Recent strategies and developments:
5.8.2.1 Partnerships, Collaborations, and Agreements:
5.9 Anhui Medipharm Co., Ltd.
5.9.1 Company Overview
5.10. Aculife Healthcare Private Limited
5.10.1 Company Overview

Companies Mentioned

  • Vifor Pharma Management Ltd.
  • Baxter International, Inc.
  • Allergan PLC (AbbVie)
  • B. Braun Melsungen AG
  • Fresenius SE & Co. KGaA
  • Grifols S.A.
  • Pfizer, Inc.
  • ICU Medical, Inc.
  • Anhui Medipharm Co., Ltd.
  • Aculife Healthcare Private Limited

Methodology

Loading
LOADING...